Clinical Trial Update: A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effects of Eletriptan 40 mg on mild versus moderate-to-severe pain in migraine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Eletriptan 40 mg (eletriptan)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Migraine | Phase 4 | Status: COMPLETED